Protocol for ADDITION-PRO: A longitudinal cohort study of the cardiovascular experience of individuals at high risk for diabetes recruited from Danish primary care

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Johansen, Nanna B ^a   Hansen, Anne Louise S ^a   Jensen, Troels M ^a   Philipsen, Annelotte ^a   Rasmussen, Signe S ^b   Jørgensen, Marit E ^a   Simmons, Rebecca K ^a,c,d   Lauritzen, Torsten ^d   Sandbæk, Annelli ^d   Witte, Daniel R ^a,e  

^a STENO DIABETES CENTER   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^d AARHUS UNIVERSITY   (Denmark)

^e LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

Aortic stiffness; Body composition; Cardiovascular disease; Complications; Diabetes; Impaired fasting glucose; Impaired glucose intolerance; Microvascular; Physical activity; Primary care

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENMARK; DIET RESTRICTION; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; LONGITUDINAL STUDY; MALE; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PATIENT SELECTION; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CLINICAL PROTOCOLS; DENMARK; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FASTING; FEMALE; GLUCOSE INTOLERANCE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT SELECTION; PRIMARY HEALTH CARE; RISK ASSESSMENT; RISK FACTORS;

MLCS; MLOWN;

EID: 84870870499     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-1078     Document Type: Article

References (28)

1. Screening for type 2 diabetes. Engelgau MM, Narayan KM, Herman WH, Diabetes Care 2000 23 10 1563 1580 10.2337/diacare.23.10.1563 11023153
2. Department of Health, Putting prevention first-vascular checks: risk assessment and management London: Department of Health 2008
3. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G, Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary C, Int J Obes Relat Metab Disord 2000 24 Suppl 3 6 S11 11063279
4. HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark. Lauritzen T, Sandbaek A, Skriver MV, Borch-Johnsen K, Diabetologia 2011 54 6 1318 1326 10.1007/s00125-011-2077-9 21340624
5. Contrasting cardiovascular risk profiles and prescribed cardio-protective therapies in newly-diagnosed type 2 diabetes identified through screening and standard practice. Webb DR, Gray LJ, Khunti K, Campbell S, Dallosso H, Davies MJ, Diabetes Research and Clinical Practice 2011 91 3 280 285 10.1016/j.diabres.2010.11.021 21194777
6. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, Diabetologia 2012 55 6 1577 1596 10.1007/s00125-012-2534-0 22526604
7. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Khunti K, BMJ 2007 334 7588 299 10.1136/bmj.39063.689375.55 17237299
8. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, Rutten GE, Sandbaek A, Sharp SJ, Simmons RK, van den Donk M, Wareham NJ, et al. Lancet 2011 378 9786 156 167 10.1016/S0140-6736(11)60698-3 21705063
9. Screening for type 2 diabetes. Lessons from the ADDITION-Europe study. van den Donk M, Sandbaek A, Borch-Johnsen K, Lauritzen T, Simmons RK, Wareham NJ, Griffin SJ, Davies MJ, Khunti K, Rutten GE, Diabet Med 2011 28 11 1416 1424 10.1111/j.1464-5491.2011.03365.x 21679235
10. Comparison of different stepwise screening strategies for type 2 diabetes: Finding from Danish general practice, Addition-DK. Dalsgaard EM, Christensen JO, Skriver MV, Borch-Johnsen K, Lauritzen T, Sandbaek A, Prim Care Diabetes 2010 4 4 223 229 10.1016/j.pcd.2010.06.003 20675208
11. A Danish diabetes risk score for targeted screening: the Inter99 study. Glümer C, Carstensen B, Sandbaek A, Lauritzen T, Jorgensen T, Borch-Johnsen K, Diabetes Care 2004 27 3 727 733 10.2337/diacare.27.3.727 14988293
12. Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms. Christensen JO, Sandbaek A, Lauritzen T, Borch-Johnsen K, Diabetologia 2004 47 9 1566 1573 10.1007/s00125-004-1496-2 15365615
13. World Health Organisation, Definition, diagnosis and classification of diabetes mellitus and its complications Geneva: Organisation WH 1999
14. Physiological analysis of middle-aged and old former athletes. Comparison with still active athletes of the same ages. Saltin B, Grimby G, Circulation 1968 38 6 1104 1115 10.1161/01.CIR.38.6.1104 5721960
15. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Webb DJ, J Hypertens 1998 16 12 Pt 2 2079 2084 9886900
16. Measurement of local pulse wave velocity: effects of signal processing on precision. Hermeling E, Reesink KD, Reneman RS, Hoeks AP, Ultrasound Med Biol 2007 33 5 774 781 10.1016/j.ultrasmedbio.2006.11.018 17383803
17. Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Mulder DJ, Water TV, Lutgers HL, Graaff R, Gans RO, Zijlstra F, Smit AJ, Diabetes Technol Ther 2006 8 5 523 535 10.1089/dia.2006.8.523 17037967
18. Ultrasonography to quantify hepatic fat content: validation by 1H magnetic resonance spectroscopy. Edens MA, van Ooijen PM, Post WJ, Haagmans MJ, Kristanto W, Sijens PE, van der Jagt EJ, Stolk RP, Obesity (Silver Spring) 2009 17 12 2239 2244 10.1038/oby.2009.154
19. Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. Stolk RP, Wink O, Zelissen PM, Meijer R, van Gils AP, Grobbee DE, Int J Obes Relat Metab Disord 2001 25 9 1346 1351 10.1038/sj.ijo.0801734 11571598
20. Reliability and validity of the combined heart rate and movement sensor Actiheart. Brage S, Brage N, Franks PW, Ekelund U, Wareham NJ, Eur J Clin Nutr 2005 59 4 561 570 10.1038/sj.ejcn.1602118 15714212
21. Hierarchy of individual calibration levels for heart rate and accelerometry to measure physical activity. Brage S, Ekelund U, Brage N, Hennings MA, Froberg K, Franks PW, Wareham NJ, J Appl Physiol 2007 103 2 682 692 10.1152/japplphysiol.00092.2006 17463305
22. Gaussian process robust regression for noisy heart rate data. Stegle O, Fallert SV, MacKay DJ, Brage S, IEEE transactions on bio-medical engineering 2008 55 9 2143 2151 18713683
23. Branched equation modeling of simultaneous accelerometry and heart rate monitoring improves estimate of directly measured physical activity energy expenditure. Brage S, Brage N, Franks PW, Ekelund U, Wong MY, Andersen LB, Froberg K, Wareham NJ, J Appl Physiol 2004 96 1 343 351 12972441
24. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 6 499 502 4337382
25. Variations in population health status: results from a United Kingdom national questionnaire survey. Kind P, Dolan P, Gudex C, Williams A, BMJ 1998 316 7133 736 741 10.1136/bmj.316.7133.736 9529408
26. Ware J, Snow KK, Kosinski M, Gandek B, SF-36 health survey. Manual & interpretation Boston, Massachusetts: Nimrod press 1993 23212429
27. Estimating physical activity energy expenditure, sedentary time, and physical activity intensity by self-report in adults. Besson H, Brage S, Jakes RW, Ekelund U, Wareham NJ, Am J Clin Nutr 2010 91 1 106 114 10.3945/ajcn.2009. 28432 19889820
28. What is the risk of mortality for people who are screen positive in a diabetes screening programme but who do not have diabetes on biochemical testing? Diabetes screening programmes from a public health perspective. Spijkerman A, Griffin S, Dekker J, Nijpels G, Wareham NJ, Journal of Medical Screening 2002 9 4 187 190 10.1136/jms.9.4.187 12518011